Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) (Q58414415)
Jump to navigation
Jump to search
scientific article published on 25 April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) |
scientific article published on 25 April 2006 |
Statements
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) (English)
Martin Bornhäuser
1 reference
Barbara Wassmann
Heike Pfeifer
Nicola Goekbuget
Dietrich W Beelen
Joachim Beck
Matthias Stelljes
Albrecht Reichle
Jolanta Perz
Rainer Haas
Arnold Ganser
Mathias Schmid
Lothar Kanz
Georg Lenz
Martin Kaufmann
Anja Binckebanck
Patrick Brück
Regina Reutzel
Harald Gschaidmeier
Stefan Schwartz
Dieter Hoelzer
25 April 2006